{
    "ba76c2a8-32c8-3846-9a51-e8445513730a": {
        "uuid": "ba76c2a8-32c8-3846-9a51-e8445513730a",
        "title": "Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report",
        "publisher": "Business Wire",
        "link": "https://finance.yahoo.com/news/gilead-reaches-number-one-spot-173000162.html",
        "providerPublishTime": 1652981400,
        "type": "STORY"
    },
    "2014bc73-3b4b-350b-9b45-3b0830c0555b": {
        "uuid": "2014bc73-3b4b-350b-9b45-3b0830c0555b",
        "title": "Gilead Stock Earns Rating Upgrade After Quick Turnaround",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/2014bc73-3b4b-350b-9b45-3b0830c0555b/gilead-stock-earns-rating.html",
        "providerPublishTime": 1652943600,
        "type": "STORY"
    },
    "d091051b-ca24-3c47-bbb6-ed8fd013a848": {
        "uuid": "d091051b-ca24-3c47-bbb6-ed8fd013a848",
        "title": "Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/biotech-stock-roundup-bbio-bmy-154103164.html",
        "providerPublishTime": 1652888463,
        "type": "STORY"
    },
    "af3fc398-891b-3455-8a7a-b7cc684039b1": {
        "uuid": "af3fc398-891b-3455-8a7a-b7cc684039b1",
        "title": "Living with Metastatic Bladder Cancer: Joey's Journey",
        "publisher": "News Direct",
        "link": "https://finance.yahoo.com/news/living-metastatic-bladder-cancer-joeys-124608797.html",
        "providerPublishTime": 1652877968,
        "type": "STORY"
    },
    "baab3845-2496-35cc-9f04-d7fa67dfbf88": {
        "uuid": "baab3845-2496-35cc-9f04-d7fa67dfbf88",
        "title": "Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting",
        "publisher": "Business Wire",
        "link": "https://finance.yahoo.com/news/gilead-kite-oncology-highlight-advances-203000908.html",
        "providerPublishTime": 1652819400,
        "type": "STORY"
    },
    "1017f35d-7e54-37c4-8ff8-f56884111184": {
        "uuid": "1017f35d-7e54-37c4-8ff8-f56884111184",
        "title": "Gilead Sciences' Can Resume Injectable Lenacapavir Trial(s) For HIV Infection",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/gilead-sciences-resume-injectable-lenacapavir-154249789.html",
        "providerPublishTime": 1652802169,
        "type": "STORY"
    },
    "67dd5edf-bc03-3259-846e-a16536fc7f65": {
        "uuid": "67dd5edf-bc03-3259-846e-a16536fc7f65",
        "title": "Gilead (GILD) HIV Studies Removed From FDA's Clinical Hold",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/gilead-gild-hiv-studies-removed-153003978.html",
        "providerPublishTime": 1652801403,
        "type": "STORY"
    },
    "8032a581-00ad-3f40-8a4a-1538a2ca9e9e": {
        "uuid": "8032a581-00ad-3f40-8a4a-1538a2ca9e9e",
        "title": "FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV",
        "publisher": "Business Wire",
        "link": "https://finance.yahoo.com/news/fda-lifts-clinical-hold-investigational-201000235.html",
        "providerPublishTime": 1652731800,
        "type": "STORY"
    }
}